Determine the necessary mass, volume, or concentration for preparing a solution.
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
SKU | Size | Availability | Price | Qty |
---|---|---|---|---|
J286824-10mg | 10mg | In stock | $165.90 | |
J286824-25mg | 25mg | In stock | $355.90 | |
J286824-50mg | 50mg | In stock | $616.90 | |
J286824-100mg | 100mg | In stock | $1,091.90 | |
J286824-250mg | 250mg | In stock | $2,457.90 |
Reversible, competitive and potent TRPV1 antagonist
Synonyms | JNJ-17203212|821768-06-3|JNJ 17203212|1-Piperazinecarboxamide, 4-(3-(trifluoromethyl)-2-pyridinyl)-N-(5-(trifluoromethyl)-2-pyridinyl)-|JNJ17203212|4-[3-(trifluoromethyl)pyridin-2-yl]-N-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carboxamide|CHEMBL25477 |
---|---|
Specifications & Purity | Moligand™, ≥99%(HPLC) |
Biochemical and Physiological Mechanisms | Reversible, competitive and potent TRPV1 antagonist (pKivalues are 6.5, 7.1 and 7.3 at rat, guinea pig and human TRPV1 respectively). Inhibits capsaicin- and H+-induced channel activation (pIC50values are 6.32 and 7.23 respectively) and exhibits antitussi |
Storage Temp | Store at -20°C,Argon charged |
Shipped In | Ice chest + Ice pads |
Grade | Moligand™ |
Action Type | CHANNEL BLOCKER |
Mechanism of action | Channel blocker of TRPV1 |
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) |
---|
Pubchem Sid | 488197410 |
---|---|
Pubchem Sid Url | https://pubchem.ncbi.nlm.nih.gov/substance/488197410 |
IUPAC Name | 4-[3-(trifluoromethyl)pyridin-2-yl]-N-[5-(trifluoromethyl)pyridin-2-yl]piperazine-1-carboxamide |
INCHI | InChI=1S/C17H15F6N5O/c18-16(19,20)11-3-4-13(25-10-11)26-15(29)28-8-6-27(7-9-28)14-12(17(21,22)23)2-1-5-24-14/h1-5,10H,6-9H2,(H,25,26,29) |
InChi Key | JFRYYGVYCWYIDQ-UHFFFAOYSA-N |
Canonical SMILES | C1CN(CCN1C2=C(C=CC=N2)C(F)(F)F)C(=O)NC3=NC=C(C=C3)C(F)(F)F |
Isomeric SMILES | C1CN(CCN1C2=C(C=CC=N2)C(F)(F)F)C(=O)NC3=NC=C(C=C3)C(F)(F)F |
PubChem CID | 11339118 |
Molecular Weight | 419.32 |
CAS Registry No. | 821768-06-3 |
---|---|
ChEMBL Ligand | CHEMBL254778 |
PubChem CID | 11339118 |
PubChem SID | 488197410 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
Lot Number | Certificate Type | Date | Item |
---|---|---|---|
C2304599 | Certificate of Analysis | Nov 07, 2022 | J286824 |
C2304600 | Certificate of Analysis | Nov 07, 2022 | J286824 |
C2304608 | Certificate of Analysis | Nov 07, 2022 | J286824 |
C2304613 | Certificate of Analysis | Nov 07, 2022 | J286824 |
C2304638 | Certificate of Analysis | Nov 07, 2022 | J286824 |
C2304639 | Certificate of Analysis | Nov 07, 2022 | J286824 |
C2304640 | Certificate of Analysis | Nov 07, 2022 | J286824 |
C2304641 | Certificate of Analysis | Nov 07, 2022 | J286824 |
C2304643 | Certificate of Analysis | Nov 07, 2022 | J286824 |
C2304644 | Certificate of Analysis | Nov 07, 2022 | J286824 |
Solubility | Solvent:DMSO, Max Conc. mg/mL: 41.93, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 41.93, Max Conc. mM: 100 |
---|
Pictogram(s) | GHS06, GHS07 |
---|---|
Signal | Danger |
Hazard Statements | H319:Causes serious eye irritation H301:Toxic if swallowed |
Precautionary Statements | P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P270:Do not eat, drink or smoke when using this product. P330:Rinse mouth. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P301+P316:IF SWALLOWED: Get emergency medical help immediately. P337+P317:If eye irritation persists: Get medical help. |
1. Swanson DM, Dubin AE, Shah C, Nasser N, Chang L, Dax SL, Jetter M, Breitenbucher JG, Liu C, Mazur C et al.. (2005) Identification and biological evaluation of 4-(3-trifluoromethylpyridin-2-yl)piperazine-1-carboxylic acid (5-trifluoromethylpyridin-2-yl)amide, a high affinity TRPV1 (VR1) vanilloid receptor antagonist.. J Med Chem, 48 (6): (1857-72). [PMID:15771431] |